Why shares in this ASX environmental company have soared 9% today

Here's a closer look at why the Phoslock Environmental Technologies Ltd (ASX: PET) share price is soaring today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Phoslock Environmental Technologies Ltd (ASX: PET) share price is up 9.5% at the time of writing following an update to the market earlier this morning on its operations in China, as well as the announcement of a new project in Brazil.

a woman

What does Phoslock do?

Phoslock is an international environmental company specialising in engineering solutions and water treatment products to remediate polluted lakes, rivers, canals and drinking water reservoirs. Phoslock has its headquarters in Sydney with offices in Brisbane, Beijing and Changxing, China, and Manchester, UK.

In 2017, Phoslock (Beijing) was formed to help remediate the massive Chinese algae and water pollution problem. Phoslock owns the patent for Phoslock, a water treatment product that inhibits the growth of harmful algal blooms (HAB) that lead to detrimental effects to both aquatic and human life. Phoslock (the product) is certified to be used in drinking water in North America, Europe, UK, Brazil, Australia and China.

The Phoslock share price has increased by over 100% during the past 12 months, peaking last August at a high of $1.52. It has since retreated, and has recently come under pressure due to coronavirus concerns. Phoslock shares are currently sitting at $0.81 with today's gains.

China update

Phoslock announced that its Beijing office is now back at work, with government approval to re-start its factory. It anticipates that production should ramp up over the next month. It noted that it has inventory held outside China to last until mid-year.

Phoslock has no treatments in China planned until late March to April and no delays are expected. It also notes there is no effect on FY2020 sales guidance.

Details of new Brazil project

Phoslock also announced that through its Brazilian licensee, Phoslock has received a contract from CEDEA to treat one of Rio de Janeiro city's main drinking reservoirs. The application has already commenced and will continue for the next 3 months, with an estimated value of over $2 million.

The company commented that this is a further instance of a growing number of local and government authorities in a range of countries having full confidence in using Phoslock in human drinking water reservoirs.

Phoslock further commented that Rio de Janeiro's high profile has generated substantial media coverage of this problem both in Brazil and internationally. Consequently, it believes that the application of Phoslock to this reservoir is likely to lead to similar applications elsewhere in Brazil and in other countries, as this particular problem is widespread.

Chair Laurence Freedman AM commented: "With each successful application of Phoslock in lakes, dams and reservoirs, our ability to dramatically transform heavily polluted waterbodies – even those suffering from eutrophication – adds to increasing global acceptance and demand for our services."

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Three brightly coloured objects against a backdrop of blue, indication three winning ASX share prices
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lacklustre session on the ASX this Thursday.

Read more »

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Deep Yellow, Develop Global, Resolute Mining, and Santos shares are pushing higher today

These shares are catching the eye on Thursday. But why?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »